Kenaz Barnie P. Cejar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kenaz Barnie P. Cejar has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Casiano Choresca
National Fisheries Research and Development Institute—Fisheries Biotechnology Center, Science City of Muñoz 3120, Nueva Ecija, Philippines
1 shared publication - Fiona L. Pedroso
College of Fisheries and Marine Sciences, Mindanao State University at Naawan, Naawan 9023, Misamis Oriental, Philippines
1 shared publication - Frenz Charish B. Hechanova
National Fisheries Research and Development Institute—Fisheries Biotechnology Center, Science City of Muñoz 3120, Nueva Ecija, Philippines
1 shared publication - Hasmin F. Villanueva
National Fisheries Research and Development Institute—Fisheries Biotechnology Center, Science City of Muñoz 3120, Nueva Ecija, Philippines
1 shared publication - Joshua Superio
National Fisheries Research and Development Institute—Fisheries Biotechnology Center, Science City of Muñoz 3120, Nueva Ecija, Philippines
1 shared publication
Latest Publications
- Open Access
Reproductive Performance of Male African Catfish (Clarias gariepinus) Breeders Under Varying Hormone Preparations and Doses Under Controlled Conditions
The African catfish (Clarias gariepinus) is an important aquaculture species in the Philippines, but it exhibits reproductive dysfunctions in captivity due to the absence of natural spawning cues and culture-induced stress. In hatcheries, sperm collection often requires sacrificing male breeders, limiting breeding program applications, and threatening genetic diversity. This study evaluated and optimized hormonal induction protocols to enhance spermiation and fertilization success in male C. gariepinus. Two experimental trials were conducted under controlled hatchery conditions. In Trial 1, human chorionic gonadotropin combined with a dopamine antagonist (hCG + DA; 5000 IU·kg−1 BW + 5 mg·kg−1 BW) and Ovaprim (1.0 mL·kg−1 BW) significantly increased circulating testosterone and estradiol levels, spermiation index, and fertilization outcomes (embryo viability, hatching, and larval survival). In Trial 2, medium to low doses of hCG + DA (3000–5000 IU·kg−1 BW + 5 mg·kg−1 BW) and Ovaprim (0.75–1.0 mL·kg−1 BW) yielded the best performance in terms of hormone levels, spermiation index, and fertilizing capabilities. The presence of a dopamine antagonist (DA) likely contributed to the efficacy of the treatments, since dopamine suppresses the secretion of gonadotropin-releasing hormone (dopaminergic inhibition), and DA counteracts this effect, increasing LH and FSH levels necessary for gametogenesis. Taken together, these results highlight the potential of optimized hormonal protocols to mitigate reproductive dysfunctions in male C. gariepinus in aquaculture settings. Further studies should refine dose combinations, assess the long-term health of broodstock, and evaluate cost-effectiveness to support sustainable broodstock management and genetic conservation.
Open AccessReproductive Performance of Male African Catfish (Clarias gariepinus) Breeders Under Varying Hormone Preparations and Doses Under Controlled Conditions
The African catfish (Clarias gariepinus) is an important aquaculture species in the Philippines, but it exhibits reproductive dysfunctions in captivity due to the absence of natural spawning cues and culture-induced stress. In hatcheries, sperm collection often requires sacrificing male breeders, limiting breeding program applications, and threatening genetic diversity. This study evaluated and optimized hormonal induction protocols to enhance spermiation and fertilization success in male C. gariepinus. Two experimental trials were conducted under controlled hatchery conditions. In Trial 1, human chorionic gonadotropin combined with a dopamine antagonist (hCG + DA; 5000 IU·kg−1 BW + 5 mg·kg−1 BW) and Ovaprim (1.0 mL·kg−1 BW) significantly increased circulating testosterone and estradiol levels, spermiation index, and fertilization outcomes (embryo viability, hatching, and larval survival). In Trial 2, medium to low doses of hCG + DA (3000–5000 IU·kg−1 BW + 5 mg·kg−1 BW) and Ovaprim (0.75–1.0 mL·kg−1 BW) yielded the best performance in terms of hormone levels, spermiation index, and fertilizing capabilities. The presence of a dopamine antagonist (DA) likely contributed to the efficacy of the treatments, since dopamine suppresses the secretion of gonadotropin-releasing hormone (dopaminergic inhibition), and DA counteracts this effect, increasing LH and FSH levels necessary for gametogenesis. Taken together, these results highlight the potential of optimized hormonal protocols to mitigate reproductive dysfunctions in male C. gariepinus in aquaculture settings. Further studies should refine dose combinations, assess the long-term health of broodstock, and evaluate cost-effectiveness to support sustainable broodstock management and genetic conservation.